133,381 Shares in Mettler-Toledo International Inc. (NYSE:MTD) Acquired by Proficio Capital Partners LLC

Proficio Capital Partners LLC acquired a new position in Mettler-Toledo International Inc. (NYSE:MTD) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 133,381 shares of the medical instruments supplier’s stock, valued at approximately $163,216,000. Proficio Capital Partners LLC owned approximately 0.63% of Mettler-Toledo International as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. State Street Corp raised its stake in Mettler-Toledo International by 1.0% in the third quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock worth $1,431,693,000 after buying an additional 9,009 shares in the last quarter. Geode Capital Management LLC raised its stake in Mettler-Toledo International by 0.8% in the third quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock worth $818,906,000 after buying an additional 4,166 shares in the last quarter. Principal Financial Group Inc. raised its stake in Mettler-Toledo International by 13.9% in the fourth quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier’s stock worth $335,977,000 after buying an additional 33,456 shares in the last quarter. Barclays PLC increased its position in shares of Mettler-Toledo International by 8.3% during the third quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock worth $384,822,000 after purchasing an additional 19,609 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after purchasing an additional 28,478 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on MTD shares. Stifel Nicolaus decreased their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and increased their price objective for the company from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. Robert W. Baird increased their price objective on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Wells Fargo & Company increased their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a report on Monday, February 10th. Finally, Evercore ISI increased their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a report on Monday, February 10th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Mettler-Toledo International has a consensus rating of “Hold” and a consensus price target of $1,368.00.

Insiders Place Their Bets

In other news, insider Gerry Keller sold 600 shares of the firm’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the sale, the insider now directly owns 6 shares in the company, valued at $8,108.04. This trade represents a 99.01 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Christian Magloth sold 790 shares of the firm’s stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the sale, the insider now owns 734 shares in the company, valued at $964,248.46. This trade represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,530 shares of company stock valued at $2,024,192. Company insiders own 1.94% of the company’s stock.

Mettler-Toledo International Price Performance

NYSE MTD opened at $1,290.12 on Thursday. The stock’s fifty day moving average price is $1,289.38 and its 200 day moving average price is $1,331.49. The company has a market cap of $26.98 billion, a price-to-earnings ratio of 31.83, a PEG ratio of 3.30 and a beta of 1.13. Mettler-Toledo International Inc. has a 1 year low of $1,142.91 and a 1 year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. Research analysts expect that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.